Stephen A Williams MD PhD

Chief Medical Officer, Somalogic Inc

Susan M. Domchek, MD

Basser Professor in Oncology at the Perelman School of Medicine of the University of Pennsylvania. Executive Director of the Basser Center for BRCA at the Abramson Cancer Center and Director of the Mariann and Robert MacDonald Cancer Risk Evaluation Center

Giorgio Sirugo, MD, PhD

Co-Director Center Penn Medicine Biobank and adjunct Associate Professor of Medicine at the University of Pennsylvania, Perelman School of Medicine.

Michael Montalto, PhD

Vice President and Head of Translational Sciences at Bristol-Myers Squibb

Michael Rivers

Vice President and Lifecycle Leader, Digital Pathology – Roche Tissue Diagnostics

Grace Cordovano, PhD

CEO & Founder , Enlightening Results, LLC

Jeffrey Shaman, PhD.MS

Chief Scientific Officer, Coriell Life Sciences

Reto Merges

Global Head of Expanding Precision Medicine Siemens Healthineers

Kimberley Ferguson

Market Development Executive, Roche Diagnostics Information Systems

Gary Palmer, MD, JD, MBA, MPH

Chief Medical Officer, Tempus Labs, Inc.

Dwight Raum

Vice President and Chief Technology Officer of Johns Hopkins Health System and Johns Hopkins University

Ben Zeskind, PhD, MBA

Co-Founder and CEO, Immuneering

Damian P. Alagia III, MD, MS, MBA, FACS, FACOG

Franchise Medical Director for Women’s Health and Reproductive Medicine for Quest Diagnostics

Christos Hatzis, PhD

Adjunct Associate Professor of Medicine, Section of Medical Oncology, Yale School of Medicine, Yale University, Clinical Mechanisms Lead, Translational Medicine, Bristol-Myers Squibb

Susan McClure

CEO & Founder, Genome Creative

Anthony Magliocco, MD

Chair of Anatomic Pathology at the Moffitt Cancer Center and Executive Director of Esoteric Laboratory Services & CEO and President Protean Biodiagnostics

Sony Tuteja, PharmD, MS

Research Assistant Professor in the Department of Medicine at the Perelman School of Medicine at the University of Pennsylvania.

George Lee, PhD

Digital Pathology Informatics Lead, Bristol Myers Squibb

Kelly E. Caudle, Pharm.D., Ph.D., BCPS

Clinical Pharmacogenetics Implementation Consortium (CPIC) Director at St. Jude Children’s Research Hospital & affiliate Assistant Professor at The University of Tennessee Health Science Center

Anil Parwani, MD, PhD

Vice Chair and Director, Anatomic Pathology, Department of Pathology, The Ohio State University Wexner Medical Center

Lori Anderson

Product Marketing Manager, XIFIN, Inc.

Shawn Glisson, MD

Medical Oncology/Hematology, Norton Cancer Institute

Okan Ekinci, MD, MBA

Chief Medical Officer, Roche Diagnostics Information Solutions

Julia A. Beaver, MD

Director, Division of Oncology Products 1 (DOP1), Office of Hematology and Oncology Products, FDA

Kenneth J. Pienta, M.D

The Donald S. Coffey Professor Urology, Director, Urology Research Laboratories, Professor Oncology, Pharmacology and Molecular Sciences, Chemical and Biomolecular Engineering

Peter Silvester

Senior Vice President and President, Life Sciences Solutions, Thermo Fisher Scientific

Luis Lasalvia, MD, MIB

Vice President, Global Medical Officer, Siemens Healthineers

Wendy Rubinstein, MD, PhD, FACP, FACMG

Deputy Medical Director of CancerLinQ®, a not-for-profit subsidiary of the American Society of Clinical Oncology (ASCO).

Robert H. Vonderheide, MD, DPhil

Director, Abramson Cancer Center, Perelman School of Medicine and the John H. Glick, MD Abramson Cancer Center’s Director Professor at the University of Pennsylvania

Erynn Gordon, MS, LCGC

VP of Clinical Operations, Genome Medical

Edward Abrahams, PhD

President, Personalized Medicine Coalition

Katie Johansen Taber, PhD

Director, Clinical Development, Myriad Women’s Health

John Quackenbush, PhD

Henry Pickering Walcott Professor of Computational Biology and Bioinformatics
Chair, Department of Biostatistics, Harvard University T.H. Chan School of Public Health

Jason H. Moore, PhD, FACMI

Edward Rose Professor of Informatics,Director, Institute for Biomedical Informatics,Director, Division of Informatics,
Department of Biostatistics, Epidemiology, & Informatics,Senior Associate Dean for Informatics ,The Perelman School of Medicine University of Pennsylvania

Erica Ramos, MS, LCGC

President, National Society of Genetic Counselors and Dir & Head of Clinical Business Development at Geisinger National Precision Health

David Roth, MD, PhD

Simon Flexner Professor and Chair of Pathology and Laboratory Medicine, Director, Penn Center for Precision Medicine, University of Pennsylvania Perelman School of Medicine

Amy M. Miller, PhD

President & CEO, Society for Women’s Health Research

Gary Palmer, MD

Chief Medical Officer, Tempus

Timothy A. Chan, MD, PhD

PaineWebber Chair in Cancer Genetics; Director, Immunogenomics and Precision Oncology Platform; Member, Human Oncology & Pathogenesis Program; Vice Chair, Department of Radiation Oncology; Director, Translational Oncology Division

Nicholas Dracopoli, PhD, Consultant

Arturo Loaiza-Bonilla, MD, MSEd, FACP

Vice Chair, CTCA Department of Medical Oncology, CTCA Philadelphia

Eric B Kmiec Ph.D

Director, Gene Editing Program,Senior Research Scientist, Center for Translational Cancer Research, Helen F. Graham Cancer Center and Research Institute

Stephanie Devaney, Ph.D

Deputy Director – All of Us Research Program, National Institutes of Health.

Tara Schmidlen, MS, CGC

Clinical Investigator / Genetic Counselor – Geisinger Health System

Andrey Antov, PhD, MBA

Program Director, Maine Cancer Genomics Initiative, The Jackson Laboratory

Ilan “Lanny” Kirsch, M.D.

Senior Vice President of Translational Medicine, Adaptive Biotechnologies

David B. Nash, MD, MBA

Dean Jefferson College of Population Health, Dr. Raymond C. & Doris N. Grandon Professor of Health Policy

Selin Kurnaz, Ph.D.

CEO – Massive Bio

Yves Lussier, MD, FACMI

Associate Vice President for Health Sciences and Chief Knowledge Officer, Executive Director, Center for Biomedical Informatics and Biostatistics, University of Arizona Health Sciences

Lorenz M. Mayr, Ph.D.

Chief Technology Officer (CTO), GE Healthcare Life Sciences

Lara Mangravite, Ph.D.

President, Sage Bionetworks

Benjamin Haibe-Kains , Ph.D.

Senior Scientist, Princess Margaret Cancer Centre (PM), University Health Network, and Associate Professor in the Medical Biophysics Department of the University of Toronto

Leslie Bucheit MS, CGC

Product Manager, Digital Products, Myriad Genetics

Michael Cantor, MD, MA

Executive Director, Clinical Informatics, Regeneron Genetics Center

Philip Empey, PharmD, PhD

Associate Director, Institute of Precision Medicine, University of Pittsburgh and UPMC.

Stephen A Williams MD PhD

Chief Medical Officer, Somalogic Inc

Giorgio Sirugo, MD, PhD

Co-Director Center Penn Medicine Biobank and adjunct Associate Professor of Medicine at the University of Pennsylvania, Perelman School of Medicine.

Michael Montalto, PhD

Vice President and Head of Translational Sciences at Bristol-Myers Squibb

Michael Rivers

Vice President and Lifecycle Leader, Digital Pathology – Roche Tissue Diagnostics

Grace Cordovano, PhD

CEO & Founder , Enlightening Results, LLC

Jeffrey Shaman, PhD.MS

Chief Scientific Officer, Coriell Life Sciences

Reto Merges

Global Head of Expanding Precision Medicine Siemens Healthineers

Kimberley Ferguson

Market Development Executive, Roche Diagnostics Information Systems

Gary Palmer, MD, JD, MBA, MPH

Chief Medical Officer, Tempus Labs, Inc.

Dwight Raum

Vice President and Chief Technology Officer of Johns Hopkins Health System and Johns Hopkins University

Ben Zeskind, PhD, MBA

Co-Founder and CEO, Immuneering

Damian P. Alagia III, MD, MS, MBA, FACS, FACOG

Franchise Medical Director for Women’s Health and Reproductive Medicine for Quest Diagnostics

Christos Hatzis, PhD

Adjunct Associate Professor of Medicine, Section of Medical Oncology, Yale School of Medicine, Yale University, Clinical Mechanisms Lead, Translational Medicine, Bristol-Myers Squibb

Susan McClure

CEO & Founder, Genome Creative

Anthony Magliocco, MD

Chair of Anatomic Pathology at the Moffitt Cancer Center and Executive Director of Esoteric Laboratory Services & CEO and President Protean Biodiagnostics

Sony Tuteja, PharmD, MS

Research Assistant Professor in the Department of Medicine at the Perelman School of Medicine at the University of Pennsylvania.

George Lee, PhD

Digital Pathology Informatics Lead, Bristol Myers Squibb

Kelly E. Caudle, Pharm.D., Ph.D., BCPS

Clinical Pharmacogenetics Implementation Consortium (CPIC) Director at St. Jude Children’s Research Hospital & affiliate Assistant Professor at The University of Tennessee Health Science Center

Anil Parwani, MD, PhD

Vice Chair and Director, Anatomic Pathology, Department of Pathology, The Ohio State University Wexner Medical Center

Lori Anderson

Product Marketing Manager, XIFIN, Inc.

Shawn Glisson, MD

Medical Oncology/Hematology, Norton Cancer Institute

Okan Ekinci, MD, MBA

Chief Medical Officer, Roche Diagnostics Information Solutions

Julia A. Beaver, MD

Director, Division of Oncology Products 1 (DOP1), Office of Hematology and Oncology Products, FDA

Kenneth J. Pienta, M.D

The Donald S. Coffey Professor Urology, Director, Urology Research Laboratories, Professor Oncology, Pharmacology and Molecular Sciences, Chemical and Biomolecular Engineering

Peter Silvester

Senior Vice President and President, Life Sciences Solutions, Thermo Fisher Scientific

Luis Lasalvia, MD, MIB

Vice President, Global Medical Officer, Siemens Healthineers

Wendy Rubinstein, MD, PhD, FACP, FACMG

Deputy Medical Director of CancerLinQ®, a not-for-profit subsidiary of the American Society of Clinical Oncology (ASCO).

Erynn Gordon, MS, LCGC

VP of Clinical Operations, Genome Medical

Edward Abrahams, PhD

President, Personalized Medicine Coalition

Katie Johansen Taber, PhD

Director, Clinical Development, Myriad Women’s Health

John Quackenbush, PhD

Henry Pickering Walcott Professor of Computational Biology and Bioinformatics
Chair, Department of Biostatistics, Harvard University T.H. Chan School of Public Health

Jason H. Moore, PhD, FACMI

Edward Rose Professor of Informatics,Director, Institute for Biomedical Informatics,Director, Division of Informatics,
Department of Biostatistics, Epidemiology, & Informatics,Senior Associate Dean for Informatics ,The Perelman School of Medicine University of Pennsylvania

Erica Ramos, MS, LCGC

President, National Society of Genetic Counselors and Dir & Head of Clinical Business Development at Geisinger National Precision Health

David Roth, MD, PhD

Simon Flexner Professor and Chair of Pathology and Laboratory Medicine, Director, Penn Center for Precision Medicine, University of Pennsylvania Perelman School of Medicine

Amy M. Miller, PhD

President & CEO, Society for Women’s Health Research

Gary Palmer, MD

Chief Medical Officer, Tempus

Timothy A. Chan, MD, PhD

PaineWebber Chair in Cancer Genetics; Director, Immunogenomics and Precision Oncology Platform; Member, Human Oncology & Pathogenesis Program; Vice Chair, Department of Radiation Oncology; Director, Translational Oncology Division

Nicholas Dracopoli, PhD, Consultant

Arturo Loaiza-Bonilla, MD, MSEd, FACP

Vice Chair, CTCA Department of Medical Oncology, CTCA Philadelphia

Eric B Kmiec Ph.D

Director, Gene Editing Program,Senior Research Scientist, Center for Translational Cancer Research, Helen F. Graham Cancer Center and Research Institute

Stephanie Devaney, Ph.D

Deputy Director – All of Us Research Program, National Institutes of Health.

Tara Schmidlen, MS, CGC

Clinical Investigator / Genetic Counselor – Geisinger Health System

Andrey Antov, PhD, MBA

Program Director, Maine Cancer Genomics Initiative, The Jackson Laboratory

Ilan “Lanny” Kirsch, M.D.

Senior Vice President of Translational Medicine, Adaptive Biotechnologies

David B. Nash, MD, MBA

Dean Jefferson College of Population Health, Dr. Raymond C. & Doris N. Grandon Professor of Health Policy

Selin Kurnaz, Ph.D.

CEO – Massive Bio

Yves Lussier, MD, FACMI

Associate Vice President for Health Sciences and Chief Knowledge Officer, Executive Director, Center for Biomedical Informatics and Biostatistics, University of Arizona Health Sciences

Lorenz M. Mayr, Ph.D.

Chief Technology Officer (CTO), GE Healthcare Life Sciences

Lara Mangravite, Ph.D.

President, Sage Bionetworks

Benjamin Haibe-Kains , Ph.D.

Senior Scientist, Princess Margaret Cancer Centre (PM), University Health Network, and Associate Professor in the Medical Biophysics Department of the University of Toronto

Leslie Bucheit MS, CGC

Product Manager, Digital Products, Myriad Genetics

Michael Cantor, MD, MA

Executive Director, Clinical Informatics, Regeneron Genetics Center

Philip Empey, PharmD, PhD

Associate Director, Institute of Precision Medicine, University of Pittsburgh and UPMC.

PMLS SIGN UP

Receive information about our 2020 conference speakers, schedule and registration.

REGISTER TODAY